Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Dubost

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
Arthritis Care & Research|July 9, 2016
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic TrialDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
Joint Bone Spine|February 22, 2021
Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)Camille Villon, Laure Orgeolet, Anne-Marie Roguedas, et al.
RMD Open|September 2, 2021
Lymphoma complicating rheumatoid arthritis: results from a French case-control studyJoanna Kedra, Raphaele Seror, Philippe Dieudé, et al.
Rheumatology (Oxford, England)|May 10, 2015
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacyDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Seminars in Arthritis and Rheumatism|July 20, 2014
Association of mastocytosis with inflammatory joint diseases: a series of 31 patientsBrigitte Bader-Meunier, Cristina Bulai Livideanu, Claire Larroche, et al.
Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.
The Journal of Infection|December 23, 2023
Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registryDamien Caillet Portillo, Xavier Puéchal, Maëva Masson, et al.
RMD Open|September 4, 2023
In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control studyLuc Pijnenburg, Margherita Giannini, Maude Bouchard-Marmen, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
Arthritis Care & Research|July 9, 2016
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic TrialDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
Joint Bone Spine|February 22, 2021
Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)Camille Villon, Laure Orgeolet, Anne-Marie Roguedas, et al.
RMD Open|September 2, 2021
Lymphoma complicating rheumatoid arthritis: results from a French case-control studyJoanna Kedra, Raphaele Seror, Philippe Dieudé, et al.
Rheumatology (Oxford, England)|May 10, 2015
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacyDivi Cornec, Valérie Devauchelle-Pensec, Xavier Mariette, et al.
Seminars in Arthritis and Rheumatism|July 20, 2014
Association of mastocytosis with inflammatory joint diseases: a series of 31 patientsBrigitte Bader-Meunier, Cristina Bulai Livideanu, Claire Larroche, et al.
Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.
The Journal of Infection|December 23, 2023
Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registryDamien Caillet Portillo, Xavier Puéchal, Maëva Masson, et al.
RMD Open|September 4, 2023
In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control studyLuc Pijnenburg, Margherita Giannini, Maude Bouchard-Marmen, et al.
Pageof 7